Detection of Paenibacillus larvae spores in honey by conventional PCR and its potential for American foulbrood control

The present study attempted to detect Paenibacillus larvae spores in naturally contaminated honeys by conventional PCR and to determine the sensitivity of the reaction with different primer pairs in order to assess its potential for American foulbrood control. For this purpose, duplicated honey sam-ples were collected from 5 bee colonies with clinical American foulbrood and 5 clinically healthy colonies in the same apiary. The samples were analysed for the presence of Paenibacillus larvae spores by culture method and subsequent PCR detection in bacterial colonies. The PCR performed directly with spore DNA failed in 6 out of the 20 honeys investigated with spore load of 10–46 cfu/g. The established sensitivity of 70% of the reaction in the present study shows that the adequate control of American foulbrood by analysis of honeys for Paenibacillus larvae spore contamination should be done by combination of culture method followed by PCR in bacterial colonies, whose sensitivity was 100%

Comparison of three methods for routine detection of staphylococcus aureus isolated from bovine mastitis

The present study aimed to compare three identification methods that are routinely used for the detection of Staphylococcus aureus as bovine mastitis agent. The evaluated methods were as followed: conventional biochemical method, commercial identification system BioLog (Gen III MicroPlate) and amplification of species-specific gene (nuc) by polymerase chain reaction (PCR). A total of 73 staphylococcal isolates were collected from 453 individual milk samples from dairy cows with subclinical and clinical mastitis from different farms in Bulgaria. This isolates were determined as 60 coagulase-positive, 3 catalase-negative and 10 coagulase-negative by conventional methods. BioLog system identified 72 isolates as S. аureus subsp. aureus and one coagulase-positive isolate as S. schleiferi subsp. coagulans. PCR amplification of nuc gene further confirmed S. аureus subsp. aureus isolates identified by the BioLog system. The primary identification of S. aureus on the basis of coagulase level led to erroneous determination of 14 (19.2%) of the isolates. Based on the findings, BioLog system and PCR appear to be more reliable detection systems for S. aureus from milk. In conclusion, the present study showed that a routine approach using a combination of phenotypic and molecular detection systems could improve S. aureus detection in milk

A hepatitis B virus causes chronic infections in equids worldwide

Preclinical testing of novel therapeutics for chronic hepatitis B (CHB) requires suitable animal models. Equids host homologs of hepatitis C virus (HCV). Because coinfections of hepatitis B virus (HBV) and HCV occur in humans, we screened 2,917 specimens from equids from five continents for HBV. We discovered a distinct HBV species (Equid HBV, EqHBV) in 3.2% of donkeys and zebras by PCR and antibodies against EqHBV in 5.4% of donkeys and zebras. Molecular, histopathological, and biochemical analyses revealed that infection patterns of EqHBV resembled those of HBV in humans, including hepatotropism, moderate liver damage, evolutionary stasis, and potential horizontal virus transmission. Naturally infected donkeys showed chronic infections resembling CHB with high viral loads of up to 2.6 × 109 mean copies per milliliter serum for >6 mo and weak antibody responses. Antibodies against Equid HCV were codetected in 26.5% of donkeys seropositive for EqHBV, corroborating susceptibility to both hepatitis viruses. Deltavirus pseudotypes carrying EqHBV surface proteins were unable to infect human cells via the HBV receptor NTCP (Na+/taurocholate cotransporting polypeptide), suggesting alternative viral entry mechanisms. Both HBV and EqHBV deltavirus pseudotypes infected primary horse hepatocytes in vitro, supporting a broad host range for EqHBV among equids and suggesting that horses might be suitable for EqHBV and HBV infections in vivo. Evolutionary analyses suggested that EqHBV originated in Africa several thousand years ago, commensurate with the domestication of donkeys. In sum, EqHBV naturally infects diverse equids and mimics HBV infection patterns. Equids provide a unique opportunity for preclinical testing of novel therapeutics for CHB and to investigate HBV/ HCV interplay upon coinfection